TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: EMDR Treatment for Psychological Trauma Among Syrian Refugees in Kilis, Randomized Controlled Trial.
Brief Summary: To implement an EMDR (Eye Movement Desensitization and Reprocessing)intervention to treat the trauma symptoms among Syrian Refugees.


Options:
A: Arm Label: Waitlist-Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Common Elements Treatment Approach; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): Common Elements Treatment Approach
B: Arm Label: NET; Type: EXPERIMENTAL; Interventions: Behavioral: Narrative Exposure Therapy | Arm Label: AC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Academic Counseling | Arm Label: WL; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Narrative Exposure Therapy; Assigned to Arm(s): NET | Intervention Type: BEHAVIORAL; Name: Academic Counseling; Assigned to Arm(s): AC
C: Arm Label: EMDR intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Eye Movement Desensitization and Reprocessing Therapy | Arm Label: Waiting List; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Eye Movement Desensitization and Reprocessing Therapy; Assigned to Arm(s): EMDR intervention
D: Arm Label: IPT arm; Type: EXPERIMENTAL; Interventions: Behavioral: interpersonal psychotherapy for groups | Arm Label: CP arm; Type: EXPERIMENTAL; Interventions: Behavioral: creative play therapy | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: interpersonal psychotherapy for groups; Assigned to Arm(s): IPT arm | Intervention Type: BEHAVIORAL; Name: creative play therapy; Assigned to Arm(s): CP arm

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Tai Chi Based Exercise Program Provided Via Telerehabilitation Compared to During Home Visits in Persons Post-Stroke Who Have Returned Home Without Intensive Rehabilitation: A Randomized, Non-inferiority Clinical Trial
Brief Summary: Telerehabilitation is a promising alternative approach that can help improve access to rehabilitation services once patients are discharged home after stroke. The investigators therefore postulate a non-inferiority hypothesis of the telerehabilitation approach compared to home visits to improve balance problem related to stroke. The platform used will be based on a technological infrastructure that was developed and tested in previous telerehabilitation studies. The study is a randomized control trial (RCT).The study population of interest will target individuals who have had a stroke who stayed in a hospital or chronic stroke population. Participants will be recruited during the hospitalization period at each of the three sites or in the community. The investigators expect to recruit 240 participants, 120 per group. The first evaluation will be conducted at recruitment to establish the baseline measures. The two other evaluations will be conducted 2 months (T2) and four months (T3) following recruitment.


Options:
A: Arm Label: Monitoring and Feedback; Type: EXPERIMENTAL; Interventions: Device: Wrist-worn wearables | Arm Label: Monitoring; Type: PLACEBO_COMPARATOR; Interventions: Device: Wrist-worn wearables | Intervention Type: DEVICE; Name: Wrist-worn wearables; Assigned to Arm(s): Monitoring, Monitoring and Feedback
B: Arm Label: Telerehabilitation Therapy; Type: EXPERIMENTAL; Interventions: Device: Telerehabilitation Therapy | Arm Label: In-Clinic Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: In-Clinic Therapy | Intervention Type: DEVICE; Name: Telerehabilitation Therapy; Assigned to Arm(s): Telerehabilitation Therapy | Intervention Type: BEHAVIORAL; Name: In-Clinic Therapy; Assigned to Arm(s): In-Clinic Therapy
C: Arm Label: effects of a incentive program for physical activity; Type: EXPERIMENTAL; Interventions: Other: incentive program for physical activity | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: incentive program for physical activity; Assigned to Arm(s): effects of a incentive program for physical activity
D: Arm Label: Tai chi program via Telerehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi based exercise program | Arm Label: Tai chi program via home visits; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tai Chi based exercise program | Intervention Type: BEHAVIORAL; Name: Tai Chi based exercise program; Assigned to Arm(s): Tai chi program via Telerehabilitation, Tai chi program via home visits

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Tai Chi Based Exercise Program Provided Via Telerehabilitation Compared to During Home Visits in Persons Post-Stroke Who Have Returned Home Without Intensive Rehabilitation: A Randomized, Non-inferiority Clinical Trial
Brief Summary: Telerehabilitation is a promising alternative approach that can help improve access to rehabilitation services once patients are discharged home after stroke. The investigators therefore postulate a non-inferiority hypothesis of the telerehabilitation approach compared to home visits to improve balance problem related to stroke. The platform used will be based on a technological infrastructure that was developed and tested in previous telerehabilitation studies. The study is a randomized control trial (RCT).The study population of interest will target individuals who have had a stroke who stayed in a hospital or chronic stroke population. Participants will be recruited during the hospitalization period at each of the three sites or in the community. The investigators expect to recruit 240 participants, 120 per group. The first evaluation will be conducted at recruitment to establish the baseline measures. The two other evaluations will be conducted 2 months (T2) and four months (T3) following recruitment.


Options:
A: Arm Label: Arm 1: Yoga Group; Type: EXPERIMENTAL; Interventions: Other: Yoga focused on strength, flexibility, and balance | Arm Label: Arm 2: Yoga Group Plus; Type: EXPERIMENTAL; Interventions: Other: Yoga focused on strength, flexibility, and balance | Arm Label: Arm 3: Wait list control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Yoga focused on strength, flexibility, and balance; Assigned to Arm(s): Arm 1: Yoga Group, Arm 2: Yoga Group Plus
B: Arm Label: physical fitness training; Type: EXPERIMENTAL; Interventions: Procedure: physical fitness training | Arm Label: relaxation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: relaxation | Intervention Type: PROCEDURE; Name: physical fitness training; Assigned to Arm(s): physical fitness training | Intervention Type: PROCEDURE; Name: relaxation; Assigned to Arm(s): relaxation
C: Arm Label: Tai chi program via Telerehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Tai Chi based exercise program | Arm Label: Tai chi program via home visits; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tai Chi based exercise program | Intervention Type: BEHAVIORAL; Name: Tai Chi based exercise program; Assigned to Arm(s): Tai chi program via Telerehabilitation, Tai chi program via home visits
D: Intervention Type: PROCEDURE; Name: exercise therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: walking rehabilitation; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety, Feasibility & Effectiveness of Acupuncture as an Adjunct to Pharmacologic Treatment for Sedation and Analgesia in Mechanically Ventilated PICU Patients - A Pilot Study
Brief Summary: The purpose of this study is to determine whether acupuncture is effective at improving comfort in children on a ventilator in the intensive care unit. Our hypothesis is that the patients receiving acupuncture will require less medications to keep them comfortable than those who receive sham or fake acupuncture.


Options:
A: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Music Therapy | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Music Therapy; Assigned to Arm(s): Interventional
B: Arm Label: Comfort Care; Type: EXPERIMENTAL; Interventions: Other: Comfort Care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Comfort Care; Assigned to Arm(s): Comfort Care | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual Care
C: Arm Label: Dynamic light; Type: EXPERIMENTAL; Interventions: Other: Dynamic Light | Arm Label: Normal Light; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Dynamic Light; Assigned to Arm(s): Dynamic light
D: Arm Label: Acupuncture; Type: EXPERIMENTAL; Interventions: Device: acupuncture | Arm Label: Sham Acupuncture; Type: SHAM_COMPARATOR; Interventions: Device: sham acupuncture | Intervention Type: DEVICE; Name: acupuncture; Assigned to Arm(s): Acupuncture | Intervention Type: DEVICE; Name: sham acupuncture; Assigned to Arm(s): Sham Acupuncture

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial (ALCHEMIST), Phase III b
Brief Summary: This study is designed to etablish the effects of spironolactone in comparison to placebo on the composite endpoint of nonfatal Myocardial Infarction (MI) and acute coronary syndrome, hospitalization for heart failure, nonfatal stroke or cardiovascular-induced death. The primary endpoint will be the time to onset of the first incident.


Options:
A: Arm Label: Spironolactone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Spironolactone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Spironolactone; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Spironolactone
C: Arm Label: Placebo Oral Tablet; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Arm Label: Spironolactone 25 MG Tablet; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone 25Mg Tablet | Intervention Type: DRUG; Name: Spironolactone 25Mg Tablet; Assigned to Arm(s): Spironolactone 25 MG Tablet | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo Oral Tablet
D: Arm Label: Spironolactone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Spironolactone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase Ib Multi-Cohort Study of MK-3475 in Subjects With Advanced Solid Tumors
Brief Summary: This study is being done to investigate the safety, tolerability and anti-tumor activity of pembrolizumab (MK-3475) in participants with advanced triple negative breast cancer (TNBC) (Cohort A), advanced head and neck cancer (Cohorts B and B2), advanced urothelial cancer (Cohort C), or advanced gastric cancer (Cohort D). Additionally, for Cohort D, data is presented for Asian Pacific (AP) participants. Only participants with programmed cell death-ligand 1 (PD-L1) expressing tumors were enrolled in Cohorts A, B, C and D. Participants in Cohort B2 were enrolled irrespective of PD-L1 status.

The primary study hypothesis is that pembrolizumab is safe and well-tolerated.


Options:
A: Intervention Type: DRUG; Name: irinotecan; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: cisplatin; Assigned to Arm(s): N/A
B: Arm Label: Cohort A: Triple Negative Breast Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort B: Head & Neck Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort C: Urothelial Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort D: Gastric Cancer; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Arm Label: Cohort B2: Head & Neck Cancer Expansion; Type: EXPERIMENTAL; Interventions: Biological: Pembrolizumab | Intervention Type: BIOLOGICAL; Name: Pembrolizumab; Assigned to Arm(s): Cohort A: Triple Negative Breast Cancer, Cohort B2: Head & Neck Cancer Expansion, Cohort B: Head & Neck Cancer, Cohort C: Urothelial Cancer, Cohort D: Gastric Cancer
C: Arm Label: Everolimus + BSC; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Best Supportive Care (BSC) | Arm Label: Placebo + BSC; Type: PLACEBO_COMPARATOR; Interventions: Drug: Everolimus placebo, Drug: Best Supportive Care (BSC) | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): Everolimus + BSC | Intervention Type: DRUG; Name: Everolimus placebo; Assigned to Arm(s): Placebo + BSC | Intervention Type: DRUG; Name: Best Supportive Care (BSC); Assigned to Arm(s): Everolimus + BSC, Placebo + BSC
D: Intervention Type: DRUG; Name: continuous infusion of 5-fluorouracil; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: combination of irinotecan and cisplatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: oral administration of S-1; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial: Comparison Between Quadrantectomy Followed by External Fractionated Radiotherapy and Quadrantectomy Associated With Intraoperative Radiotherapy in Women >= 48 Years of Age Affected by Early-stage Breast Carcinoma.
Brief Summary: The purpose of this study is to investigate the efficacy of exclusive intraoperative radiation therapy after conserving surgery in early-stage breast cancer compared with whole breast radiotherapy. The primary outcome was the rate of ipsilateral true recurrence ( any recurrence at or close to primary tumor bed) and new ipsilateral tumors ( any recurrence occurring in quadrants other than the previous one) and the recurrence free survival.


Options:
A: Arm Label: ELIOT; Type: EXPERIMENTAL; Interventions: Radiation: intraoperative radiotherapy | Arm Label: EXTERNAL RT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: external fractionated radiotherapy | Intervention Type: RADIATION; Name: external fractionated radiotherapy; Assigned to Arm(s): EXTERNAL RT | Intervention Type: RADIATION; Name: intraoperative radiotherapy; Assigned to Arm(s): ELIOT
B: Arm Label: Standard or Hypofractionated radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Whole Breast Irradiation + Boost or Hypofractionated irradiation | Arm Label: Accelerated Partial Breast Irradiation (APBI); Type: EXPERIMENTAL; Interventions: Radiation: Accelerated partial breast irradiation | Intervention Type: RADIATION; Name: Whole Breast Irradiation + Boost or Hypofractionated irradiation; Assigned to Arm(s): Standard or Hypofractionated radiotherapy | Intervention Type: RADIATION; Name: Accelerated partial breast irradiation; Assigned to Arm(s): Accelerated Partial Breast Irradiation (APBI)
C: Arm Label: APBI utilizing 3D-CRT radiation; Type: EXPERIMENTAL; Interventions: Radiation: APBI utilizing 3D-CRT radiation | Arm Label: Whole breast irradiation; Type: OTHER; Interventions: Radiation: Whole breast irradiation | Intervention Type: RADIATION; Name: APBI utilizing 3D-CRT radiation; Assigned to Arm(s): APBI utilizing 3D-CRT radiation | Intervention Type: RADIATION; Name: Whole breast irradiation; Assigned to Arm(s): Whole breast irradiation
D: Arm Label: Intra-operative radiotherapy; Type: EXPERIMENTAL; Interventions: Device: Intrabeam | Arm Label: Post-operative radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Post-operative radiotherapy | Intervention Type: DEVICE; Name: Intrabeam; Assigned to Arm(s): Intra-operative radiotherapy | Intervention Type: RADIATION; Name: Post-operative radiotherapy; Assigned to Arm(s): Post-operative radiotherapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial: Comparison Between Quadrantectomy Followed by External Fractionated Radiotherapy and Quadrantectomy Associated With Intraoperative Radiotherapy in Women >= 48 Years of Age Affected by Early-stage Breast Carcinoma.
Brief Summary: The purpose of this study is to investigate the efficacy of exclusive intraoperative radiation therapy after conserving surgery in early-stage breast cancer compared with whole breast radiotherapy. The primary outcome was the rate of ipsilateral true recurrence ( any recurrence at or close to primary tumor bed) and new ipsilateral tumors ( any recurrence occurring in quadrants other than the previous one) and the recurrence free survival.


Options:
A: Arm Label: Intra-operative radiotherapy; Type: EXPERIMENTAL; Interventions: Device: Intrabeam | Arm Label: Post-operative radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Post-operative radiotherapy | Intervention Type: DEVICE; Name: Intrabeam; Assigned to Arm(s): Intra-operative radiotherapy | Intervention Type: RADIATION; Name: Post-operative radiotherapy; Assigned to Arm(s): Post-operative radiotherapy
B: Arm Label: ELIOT; Type: EXPERIMENTAL; Interventions: Radiation: intraoperative radiotherapy | Arm Label: EXTERNAL RT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: external fractionated radiotherapy | Intervention Type: RADIATION; Name: external fractionated radiotherapy; Assigned to Arm(s): EXTERNAL RT | Intervention Type: RADIATION; Name: intraoperative radiotherapy; Assigned to Arm(s): ELIOT
C: Arm Label: Standard or Hypofractionated radiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Whole Breast Irradiation + Boost or Hypofractionated irradiation | Arm Label: Accelerated Partial Breast Irradiation (APBI); Type: EXPERIMENTAL; Interventions: Radiation: Accelerated partial breast irradiation | Intervention Type: RADIATION; Name: Whole Breast Irradiation + Boost or Hypofractionated irradiation; Assigned to Arm(s): Standard or Hypofractionated radiotherapy | Intervention Type: RADIATION; Name: Accelerated partial breast irradiation; Assigned to Arm(s): Accelerated Partial Breast Irradiation (APBI)
D: Arm Label: APBI; Type: EXPERIMENTAL; Interventions: Radiation: Accelerated partial breast irradiation | Arm Label: EBRT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: External beam whole breast irradiation | Intervention Type: RADIATION; Name: Accelerated partial breast irradiation; Assigned to Arm(s): APBI | Intervention Type: RADIATION; Name: External beam whole breast irradiation; Assigned to Arm(s): EBRT

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement; A Prospective Triple-blinded Randomized Controlled Trial.
Brief Summary: The purpose of this study is to determine 1) the effective dosage of intra-articular tranexamic acid injection for controlling blood loss and blood transfusion requirement in conventional total knee replacement, and 2) whether the blood loss reduction effect depended on the dose of tranexamic acid used.


Options:
A: Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Physiologic saline | Arm Label: TXA-250 group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid, Drug: Physiologic saline | Arm Label: TXA-500 group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid, Drug: Physiologic saline | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): TXA-250 group, TXA-500 group | Intervention Type: DRUG; Name: Physiologic saline; Assigned to Arm(s): Control group, TXA-250 group, TXA-500 group
B: Arm Label: tranexamic acid - The G1 group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acide Tranexamique | Arm Label: tranexamic acid - The G2 group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Acide Tranexamique | Intervention Type: DRUG; Name: Acide Tranexamique; Assigned to Arm(s): tranexamic acid - The G1 group, tranexamic acid - The G2 group
C: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Comparator; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Experimental | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Comparator
D: Arm Label: Vitagel; Type: EXPERIMENTAL; Interventions: Device: Vitagel | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Vitagel; Assigned to Arm(s): Vitagel

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cost-effectiveness of Early Surgery Versus Conservative Treatment With Optional Delayed Meniscectomy in Older Patients. A Randomized Controlled Trial.
Brief Summary: The purpose of this study is to determine the effectiveness of both arthroscopic knee surgery and physical therapy in the treatment of non-obstructive meniscal injuries in older patients.

The investigators assume equal improvement of physical function in both groups and reduced costs with conservative treatment.


Options:
A: Arm Label: Surgical; Type: EXPERIMENTAL; Interventions: Procedure: Arthroscopic partial menisectomy, Other: Postoperative rehabilitative physical therapy | Arm Label: Nonoperative; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard physical therapy | Intervention Type: PROCEDURE; Name: Arthroscopic partial menisectomy; Assigned to Arm(s): Surgical | Intervention Type: OTHER; Name: Standard physical therapy; Assigned to Arm(s): Nonoperative | Intervention Type: OTHER; Name: Postoperative rehabilitative physical therapy; Assigned to Arm(s): Surgical
B: Arm Label: Arthroscopic Partial Meniscectomy; Type: EXPERIMENTAL; Interventions: Procedure: Arthroscopic Partial Meniscectomy | Arm Label: Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Physical Therapy | Intervention Type: PROCEDURE; Name: Arthroscopic Partial Meniscectomy; Assigned to Arm(s): Arthroscopic Partial Meniscectomy | Intervention Type: OTHER; Name: Physical Therapy; Assigned to Arm(s): Physical Therapy
C: Arm Label: Arthroscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Knee arthroscopy | Arm Label: Exercise therapy; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Knee arthroscopy; Assigned to Arm(s): Arthroscopy
D: Arm Label: Arthroscopic partial meniscectomy; Type: EXPERIMENTAL; Interventions: Procedure: Arthroscopic partial menisectomy | Arm Label: Exercise Therapy; Type: EXPERIMENTAL; Interventions: Other: Supervised neuromuscular and strength training | Intervention Type: PROCEDURE; Name: Arthroscopic partial menisectomy; Assigned to Arm(s): Arthroscopic partial meniscectomy | Intervention Type: OTHER; Name: Supervised neuromuscular and strength training; Assigned to Arm(s): Exercise Therapy

Answer: B